Stefan Mark Nidorf
8PUBLICATIONS
33CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|May 15, 2025
Cardiovascular Benefit of Colchicine in Relation to Baseline Risk: A Secondary Analysis of the LoDoCo2 Trial.Niekbachsh Mohammadnia, Britta E Wesselink, Willem A Bax
|Feb 25, 2025
Sex Differences in Permanent Discontinuation of Trial Medication in Chronic Coronary Artery Disease: The LoDoCo2 Trial.Marte F van der Bijl, Jenny van der Veen, Aernoud T L Fiolet
|Apr 10, 2024
Low-dose colchicine for atherosclerosis: long-term safety.Stefan Mark Nidorf, Eldad Ben-Chetrit, Paul M Ridker
|Jul 06, 2023
Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery disease.Pascal M Burger, Jannick A N Dorresteijn, Aernoud T L Fiolet
|May 29, 2023
Association of Low-Dose Colchicine With Incidence of Knee and Hip Replacements : Exploratory Analyses From a Randomized, Controlled, Double-Blind Trial.Michelle W J Heijman, Aernoud T L Fiolet, Arend Mosterd
|Oct 25, 2022
The challenge of reducing residual cardiovascular risk in patients with chronic kidney disease.Stefan Mark Nidorf
Pageof 2
Frequent Collaborators
5 joint publications
Arend Mosterd
5 joint publications
Jan H Cornel
3 joint publications
Aernoud T L Fiolet
3 joint publications
John W Eikelboom
2 joint publications
Charley A Budgeon
2 joint publications
Willem A Bax
1 joint publications
Massimo Imazio
1 joint publications
Amber van Broekhoven
1 joint publications
Michelle W J Heijman
1 joint publications
Jan G P Tijssen
